Viridian Therapeutics, Inc. (VRDN)
NASDAQ·Healthcare·Biotechnology
$20.38
+5.54%
Mkt Cap $1.79B
Analyst Ratings
Buy
20
Hold
1
Sell
0
Price Target (41 analysts)
$36.88
Range $26.00 – $45.00
Implied Upside
+81.0%
Consensus $36.88 vs current $20.38
NASDAQ·Healthcare·Biotechnology
$20.38
+5.54%
Mkt Cap $1.79B
Buy
20
Hold
1
Sell
0
Price Target (41 analysts)
$36.88
Range $26.00 – $45.00
+81.0%
Consensus $36.88 vs current $20.38